AlcNow® InView™: A new simple method for office-based glycohemoglobin measurement

Journal of Diabetes Science and Technology

Volumn 1, Issue 6, 2007, Pages 879-884

  Mattewal, Amarbir ^a   Aldasouqi, Saleh ^a   Solomon, David ^a   Gossain, Ved ^a   Koller, Anthony ^b  

^a MICHIGAN STATE UNIVERSITY   (United States)

^b Claire Dart Stroke Center Sparrow Hospital   (United States)

Author keywords

Alc; AlcNow; Diabetes; Glycohemoglobin; Point of care testing; Portable alc measurement

Indexed keywords

EID: 57349177602     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229680700100612     Document Type: Article

References (14)

1. American Diabetes Association. Diabetes statistics [accessed 2007 May 31]. Available from: http://www.diabetes.org/diabetes-statistics. jsp.
2. Hogan P, Dall T, Nikolov P; American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003 Mar; 26(3):917-32.
3. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 1993 Jul. 29;329(5):304-9.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998 Sep. 12;352(9131):837-53.
5. Diabetes Control and Complications Trial (DCCT): results of feasibility study. The DCCT Research Group. Diabetes Care. 1987 Jan-Feb; 10(1):1-19.
6. Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennill A, Goldstein DE. Defining the relationship between plasma glucose and HbAlc: analysis of glucose profiles and HbAlc in the Diabetes Control and Complications Trial. Diabetes Care. 2002 Feb; 25(2):275-8.
7. Little RR. Glycated hemoglobin standardization - National Glycohemoglobin Standardization Program (NGSP) perspective. Clin Chem Lab Med. 2003 Sep; 41(9):1191-8.
8. Thaler LM, Dunbar VG, Ziemer DC, Phillips LS, Gallina DL, El-Kebbi IM, Cook CB. Diabetes in urban African-Americans. XVII. Availability of rapid HbAlc measurements enhances clinical decision making. Diabetes Care. 1999 Sep; 22(9):1415-21.
9. Cagliero E, Levina EV, Nathan DM. Immediate feedback of HbAlc levels improves glycemic control in type 1 and insulin treated type 2 diabetic patients. Diabetes Care. 1999 Nov; 22(11):1785-9.
10. Ferenczi A, Reddy K, Lorber DL. Effect of immediate hemoglobin A1c results on treatment decisions in office practice. Endocr Pract. 2001 Mar-Apr; 7(2):85-8.
11. Miller CD, Barnes CS, Phillips LS, Ziemer DC, Gallina DL, Cook CB, Maryman SD, El-Kebbi IM. Rapid Alc availability improves decision making in an urban primary care clinic. Diabetes Care. 2003 Apr; 26(4):1158-63.
12. Marrero D, Vandagriff J, Gibson R, Fineberg S, Fineberg N, Hiar C, Crowley L. Immediate HbAlc results. Performance of new HbAlc system in pediatric outpatient population. Diabetes Care. 1992 Aug; 15(8):1045-9.
13. Guerci B, Durain D, Leblanc H, Rouland JC, Passa P, Godeau T, Charbonnel B, Mathieu Daude JC, Boniface H, Monnier L, Dauchy F, Slama G, Drouin P. Multicenter evaluation of the DCA 2000 system for measuring glycated hemoglobin. DCA Study Group. Diabetes Metab. 1997 Jun; 23(3):195-201.
14. Sicard DA, Taylor JR. Comparison of point of care HbAlc test versus standardized laboratory testing. Ann Pharmacother. 2005 Jun; 39(6):1024-8.